{"ticker": {"uuid": "84a58f12-cee7-46ca-a30e-35f79cf11901", "symbol": "HAE", "name": "Haemonetics Corporation", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Haemonetics Price Target Raised to $90.00/Share From $85.00 by Mizuho", "summary": "Mizuho has raised its price target for Haemonetics (NYSE: HAE) to $90.00 per share, an increase from the previous target of $85.00. This adjustment in the price target indicates an updated valuation of the company by the analyst firm.", "url": "https://www.moomoo.com/news/post/73026893/haemonetics-price-target-raised-to-90-00-share-from-85", "source_name": "Moomoo", "published_at": "2026-07-16T00:12:16", "published_display": "16 Jul 2026 00:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Is Maintained at Outperform by Mizuho", "summary": "Mizuho has maintained its Outperform rating on Haemonetics (NYSE: HAE) with a price target of $125.00. This continued positive outlook suggests the analyst firm believes in the company's strong performance potential. Investors will likely watch Haemonetics' future financial resul", "url": "https://www.moomoo.com/news/post/73026894/haemonetics-is-maintained-at-outperform-by-mizuho?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-15T19:12:16", "published_display": "15 Jul 2026 19:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE Maintained by Mizuho -- Price Target Raised to $90", "summary": "Mizuho has maintained an Outperform rating for Haemonetics (HAE), raising its price target from $85.00 to $90.00. GuruFocus identifies HAE as 10.5% undervalued with a strong GF Score\u2122 of 87/100, citing high profitability, growth potential, and attractive valuation. Insiders have ", "url": "https://www.gurufocus.com/news/8960850/hae-maintained-by-mizuho-price-target-raised-to-90", "source_name": "GuruFocus", "published_at": "2026-07-15T19:10:41", "published_display": "15 Jul 2026 19:10", "sentiment": "positive", "sentiment_pct": 79, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Haemonetics Corp (HAE) a Bargain After 3.2% Drop? GF Value Sa", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOdUpkcXd2QTVWYzIxeEloRTV2d2tEOURtUE5MQ3M3OHVEb2lzY2lFTUpiX3BoV1N3WmpRTlZoTWh6VXVFUkprSEkzMXAwNkttREV0Sm1oZGRBTmRZaWpxb3REeEI3UkExa0NIdDBncUZfV0tTUThmX3JHRHgwcEVXaEVNU25saGhWa3VycHBjRU0xT1c2c25KcGIxUkM3RW1XZGliM0FMTTBaLW5Bbl9Ibmw2NjhjZGFkMWR0MWJKazctdw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T00:25:28+00:00", "published_display": "15 Jul 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "HAE5817431 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the Haemonetics Corporation 2.5% 01-JUN-2029 bond (HAE5817431 FINRA). It details the issuer's description, issue and maturity dates, outstanding amount, face value, and coupon rate. The bond profile also includes a company overview of Haemone", "url": "https://www.tradingview.com/symbols/FINRA-HAE5817431/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T14:39:32", "published_display": "13 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Joins Russell Indexes As Investors Ask If The Stock Is Still Undervalued", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T00:02:09+00:00", "published_display": "11 Jul 2026 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Downgrades Haemonetics (HAE)", "summary": "Raymond James has downgraded Haemonetics (HAE) stock from an \"Outperform\" rating to a \"Market Perform\" rating. This change reflects the analyst's updated view on the company's financial prospects and stock performance. Investors and market watchers often follow such downgrades as", "url": "https://www.msn.com/en-us/money/markets/raymond-james-downgrades-haemonetics-hae/ar-AA1Kp3KC?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-10T15:10:43", "published_display": "10 Jul 2026 15:10", "sentiment": "negative", "sentiment_pct": 15, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026", "summary": "Haemonetics has announced that it will release its first quarter fiscal year 2027 financial results on Thursday, August 6, 2026. The company will also host a conference call and webcast on the same day at 8:00 a.m. EDT to discuss these results. Interested parties can access the w", "url": "https://www.moomoo.com/news/post/72668040/press-release-haemonetics-sets-date-for-publishing-first-quarter-fiscal", "source_name": "Moomoo", "published_at": "2026-07-09T17:39:32", "published_display": "09 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE stock holds steady as investors track Haemonetics' product mix", "summary": "Haemonetics (HAE) stock remains in focus due to its blood-management and hospital product offerings, which form the core of its business model. The company, listed on the NYSE, specializes in medical technology for blood collection, plasma processing, and hospital workflows, rely", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/hae-stock-holds-steady-as-investors-track-haemonetics-product-mix/69733227", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:39:18", "published_display": "09 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026", "summary": "Haemonetics Corporation announced it will publish its first quarter fiscal year 2027 financial results on Thursday, August 6, 2026, at 6:00 am ET. The company will also host a conference call for investors and analysts at 8:00 am ET on the same day to discuss the results and answ", "url": "https://www.marketscreener.com/news/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2027-results-august-6-2026-ce7f5ed9dd8cf523", "source_name": "www.marketscreener.com", "published_at": "2026-07-08T20:10:37", "published_display": "08 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics sets Aug. 6 call for Q1 2027 results", "summary": "Haemonetics (NYSE: HAE) has announced that it will publish its first-quarter fiscal year 2027 financial results on Thursday, August 6, 2026, at 6:00 a.m. ET. The company will also host a conference call for investors and analysts at 8:00 a.m. ET on the same day to discuss the res", "url": "https://www.stocktitan.net/news/HAE/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2027-yrgjsj97ghh7.html", "source_name": "Stock Titan", "published_at": "2026-07-08T20:10:36", "published_display": "08 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp updates investors on blood management business. Operational focus supports long-ter HAEMONETICS CORP updates investors on blood management business. Operational focus supports long-term growth outlook", "summary": "Haemonetics Corp, a medical technology company specializing in blood management systems, continues to update investors on its operational focus. The company invests in core platforms and software tools to support hospitals and blood centers globally, aiming to improve patient car", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-updates-investors-on-blood-management-business/69705376", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T12:11:16", "published_display": "06 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Haemonetics Corporation \u2013 SWB:HAZ", "summary": "This article provides financial information for Haemonetics Corporation (SWB:HAZ), specifically focusing on its enterprise value to EBIT forward. It indicates that the market was closed with no trades recorded and presents a navigation link to financial data on TradingView.", "url": "https://www.tradingview.com/symbols/SWB-HAZ/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:11:16", "published_display": "06 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?", "summary": "Haemonetics Corporation (HAE) is poised for growth driven by its Plasma franchise and the NexSys PCS system. Despite strong performance in its Plasma business and the potential of new technology, concerns remain regarding its debt-burdened balance sheet and competitive market. Th", "url": "https://www.tradingview.com/news/zacks:ae2093cd5094b:0-is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-07-03T17:10:10", "published_display": "03 Jul 2026 17:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp updates plasma strategy, shares tracked against U.S. medtech peers", "summary": "Haemonetics Corp is adjusting its plasma collection strategy and focusing on growth in its key business lines, particularly automated plasmapheresis platforms and blood management systems for hospitals. The company provides equipment and software for plasma centers rather than ow", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-updates-plasma-strategy-shares-tracked-against-u-s/69654785", "source_name": "AD HOC NEWS", "published_at": "2026-06-29T18:39:28", "published_display": "29 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2500 Value Benchmark", "summary": "Haemonetics Corporation (NYSE: HAE), a medical technology company specializing in blood and plasma technologies, has been added to the Russell 2500 Value Benchmark. This inclusion is part of several recent additions to various Russell indices, reflecting increased recognition and", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2500-value-benchmark-ce7f5fdfdf8cfe23", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:40:21", "published_display": "29 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2000 Value Benchmark", "summary": "Haemonetics Corporation (NYSE: HAE), a medical technology company, has been added to the Russell 2000 Value Benchmark. This update reflects the company's position within the small-cap value segment of the market. The article also provides recent news and financial data for Haemon", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2000-value-benchmark-ce7f5fded18ef321", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:39:28", "published_display": "29 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2000 Value-Defensive Index", "summary": "Haemonetics Corporation (NYSE: HAE) has been added to the Russell 2000 Value-Defensive Index. This medical technology company specializes in solutions for critical medical needs, including hospital technologies, plasma collection, and blood center products. The addition to the in", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2000-value-defensive-index-ce7f5fdedb8afe24", "source_name": "marketscreener.com", "published_at": "2026-06-29T02:11:32", "published_display": "29 Jun 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics\u2019 Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE)", "summary": "Haemonetics Corporation (HAE) has been included in several Russell value and defensive indexes, which is expected to increase passive ownership and liquidity, reinforcing its position as a value-tilted medtech stock. While this inclusion will impact trading dynamics, the core inv", "url": "https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/haemonetics-broad-russell-value-index-inclusion-might-change", "source_name": "Simply Wall Street", "published_at": "2026-06-29T01:11:32", "published_display": "29 Jun 2026 01:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article provides financial information for Haemonetics Corporation (NYSE: HAE), specifically detailing its enterprise value to revenue forward metric. The content, sourced from TradingView, focuses on the company's financials within the Health Technology sector.", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T15:40:33", "published_display": "27 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article from TradingView displays the \"Price to sales forward\" financial metric for Haemonetics Corporation (NYSE:HAE). The page appears to be a financial data presentation without explanatory text, showing only the period, value, and change for this specific metric. It is p", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:40:21", "published_display": "27 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page provides financial data for Haemonetics Corporation (HAZ) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to revenue forward. It is a data-centric page without a narrative article.", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:40:21", "published_display": "27 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page from TradingView provides financial data for Haemonetics Corporation (FWB:HAZ), specifically its price to sales forward. It shows that the market is currently closed with no trades recorded for the stock. The content focuses purely on this financial metric without furth", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:09:45", "published_display": "27 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This page provides financial information for Haemonetics Corporation (NYSE: HAE), specifically detailing its forward Price to Earnings (P/E) ratio. The content is primarily a financial data point from TradingView, indicating no current trades for the company and listing various f", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T22:09:45", "published_display": "26 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page from TradingView provides financial information for Haemonetics Corporation (FWB:HAZ), specifically focusing on its Price to Earnings (forward) metric. It lists the company on the Frankfurt Stock Exchange within the Health Technology and Medical Specialties sectors. The", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:40:27", "published_display": "26 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article presents financial information for Haemonetics Corporation (NYSE: HAE), specifically focusing on its Enterprise Value to EBITDA (EV/EBITDA) forward metric. It highlights that this data point is accessible through the TradingView platform, which provides various finan", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:27", "published_display": "26 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation Actuals & Estimates (NYSE:HAE)", "summary": "This article provides financial actuals and estimates for Haemonetics Corporation (NYSE: HAE), including details on its stock performance, analyst forecasts, earnings, revenue, and market capitalization. It highlights the company's recent stock price movements, upcoming earnings ", "url": "https://www.tradingview.com/symbols/NYSE-HAE/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:29", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Haemonetics Corporation \u2013 SWB:HAZ", "summary": "This article provides financial data for Haemonetics Corporation (SWB:HAZ) on the Stuttgart Stock Exchange, specifically focusing on its Enterprise Value to EBITDA forward. The content appears to be a stub or a section within a larger financial platform, offering no specific valu", "url": "https://www.tradingview.com/symbols/SWB-HAZ/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:40:29", "published_display": "26 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp (HAE) Stock Up 6.5% and Still Undervalued -- GF Score: 84/100", "summary": "Haemonetics Corp (HAE) saw its stock rise by 6.5% to $77.62 on June 25, 2026, and is considered 8.5% undervalued compared to its GF Value\u2122 of $84.82. The company holds a strong GF Score\u2122 of 84/100, driven by high profitability and growth ranks, despite a neutral stance from insid", "url": "https://www.gurufocus.com/news/8932858/haemonetics-corp-hae-stock-up-65-and-still-undervalued-gf-score-84100", "source_name": "GuruFocus", "published_at": "2026-06-26T00:40:29", "published_display": "26 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Haemonetics Corporation (HAE) stock, including analyst price targets, current stock performance, and financial data. It covers historical prices, volatility, market capitalization, upcoming earnings reports, and revenue details, while also add", "url": "https://www.tradingview.com/symbols/NYSE-HAE/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T23:40:34", "published_display": "25 Jun 2026 23:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Jumps 5.9% Amid Sector-Wide Rally", "summary": "Haemonetics Corporation (HAE) saw its stock surge by 5.9% on Thursday, closing at $77.16 due to a broad sector-wide rally, not company-specific news. The strong performance, which included sector peers like QDEL and NEOG also making gains, suggests a general investor rotation int", "url": "https://news.alphastreet.com/haemonetics-jumps-5-9-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-06-25T19:39:48", "published_display": "25 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp (HAE) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Haemonetics Corp (HAE), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of June 18, 2026, HAE has a price momentum score of 9.04, trading between a resistance of ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hae/technical", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:45", "published_display": "17 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look At Haemonetics (HAE) Valuation After Its New Apheresis And MedSurg Segment Realignment", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/look-haemonetics-hae-valuation-apheresis-161042644.html", "source_name": "Simply Wall St.", "published_at": "2026-06-09T16:10:42+00:00", "published_display": "09 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAEMONETICS CORP ($HAE) President and CEO 2026 Pay Revealed", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObUcxZ1dEN2czb05ac0FtaDlPTXo3RVNqUGgxTEZQYmMwcWZKSC1yUHBlRmQwOGR1QzdKNEp6MFlqS3VGcDNUeXRkU0RWRWN2MkdjVkM3SVZKUFJsTWQtN196NDJ4VzN4cnBkbW5ObGp5c1Bva0xGWTkyRFFoYTluTjJ5NG41dENES1R5eGZORzhRS045czhvcUZTOUUzVTA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Haemonetics (HAE) Stock Price Reflecting Its Recent 29% Monthly Surge Accurately", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Narrows Reporting Structure", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/haemonetics-narrows-reporting-structure-110406793.html", "source_name": "MT Newswires", "published_at": "2026-06-05T11:04:06+00:00", "published_display": "05 Jun 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Updates Financial Reporting Segments", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/haemonetics-updates-financial-reporting-segments-103000347.html", "source_name": "PR Newswire", "published_at": "2026-06-05T10:30:00+00:00", "published_display": "05 Jun 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (NYSE: HAE) consolidates business into new Apheresis and MedSurg segments", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSWN6Q09vUkV6N2tYb2pURW16QXYzd2drQUk5OXRtWGctYzQzZXA0SWRTWllKX3JIQWpmRmFuckQ1aE9SSll1VGNUUWs5dVI1OUdKWlBpSnBPWFl3N204ckJJZzRBZzNxRGFjZ3NnUjFEQWdrbWQwREJIbGg0SEFTOUVZem9BRnNVdnVrWWNUdzFoU2c4NkQzYXkwSXM2NGltRVVzR0Z1TQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics' (NYSE:HAE) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWld5OTQtb2RiRDNtd2hRc1dhMGxRel9LS2JJWHY2OVNYNVAzNWRvWmxpQkZnd213LWdwZDRqczVhUFhNWV9OZTdSTXpIYnBJd2RzTkhlMzA0MktZdVVlaW85bXc3MW0tZF9KeE9MZ2lfTVBYY2s5UWpmem11REZuT3lHcmJQUjgzTlFDeFluZFRCVHh1NjZnZDkySkF3Q0VOLXhUaEpwd2R1UlJraFhxS25ER2taQmx2QS1KZGhQaEM3aVhWdE8yN9IBzgFBVV95cUxNemsxSzQ3REtiU0JYVHJlZFVMNnNCcGxIaWhGN1JWSnJfTGxyY2dyOExjNE1GemtEWjZLdm1SWUJCaHY4bHhXY1dXeWd6N2hZSzN4a1ZZdUVtYlItSmpCU09fcGtMWDQxV052UFJ0UnM0RWJBVFRDQnplUWxfem84NzFjQVV4ZS1kcjBYUlNxeXVLeGZxTEI2azNIc0dYcWdXcXBrNDd0YndlTnRBM1Z6aGtXdFRPZGtXZFhUSjFKb0JfWUFMeF82MmwyVFJBdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQRmNnMW43N2hBMDlEVV9IR09FdHFrb2pKTDJVX01qWUlVRlY5Yl9sNmZ1UTlBaGtaandPRUtiWTJOQUludWgxT09DbUZURnBHZmhjVTNqT05YYmVuY3pXY0t5NVFmU0dkYWkwNEIzalJzMXNRSmU0NWxiczR0a2JQUElPTGhBV1czeXoyUjJaaGFDd1U?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOWHZvUkljRWNUaEtTQTRmcEY1NkNnclNqaWlRRDB6WHhkRXV4OUxKR241NGh5Uk1xbEtHX3RObXhuYlQ5M2poVnc2MVJtTGNQcDRJOHhfbVJCWlN4bl9iRUhrMFpseHdSaHRJWWxZb1F0QjVIUndRZzlHUGJrRVZYbVVkdjJlbExOQVNzOXc3cFhjZUxHcGc?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics upgraded at BofA on conservative outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQTS05VzRjV0Jsa2ZRRVM4R2hhd19rbjRjSlJaLUlDaWp3cWNraERBTHJZMWhiRlF2TXA4OEZJaFM3LUNsREVubzYyR3pwVHNhQlZWeGlrYlBlVHY0Qy1sV3RERVJaNm5vVEU3emdVcWRqZHVHUFlZLWtiYzNDQkNoU2xxdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Haemonetics (HAE) Have Enduring Growth Potential?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNclJNOEJZNDgtZ0J0OVFxQkRxZmQycWUwVW1ObkxqZ3dkOXdQbW5IbWtRSmtoYVRBMVRqclh0NS1uUElPWkUxbkJGWllqZVFxYkhxUHZnYmI5eWZURTFBN09CRkFFSUl2ZUVBMkFJN0RzeTRZSWxNTzBQY1Y5WlVjVVlMR1BZMlNXVEtxc0RTX0phME8xLUFvSS02WkNoSFNiNm5F?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNaTE2aVBzMS16SVQzN0VoUGh3blViYmJYVmxRazVscjFzcjk0VkVXMEZUYU0zSERNTzE2SDFKX0RlV3ZQeVI0RUgzSFlFQXpOOW9uempQQXRiM2E1MElDSEtVd2JDakFFcDZpSEFkZDhBOHFCbUhQcFhlS19tY3FZN0ZJcUh5eEwzM1dVTUQ4TmUwMmFuczU3Q2REVUtUYlBPeUpQTg?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) One Off Loss And Margin Hit Challenge Bullish Earnings Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQcTBTVmNBNkptbHRuRm1mQ0FYT25HMlJxdmtjSXpWTUdTanUzSkJzczQ5bld2YVh2SHQyWFJoSFAxdUczME9RcVYyZk4xUWI5a0ZHSDRTQ0VGX3JTY3E3NExJVlhfVFVFeE5XZE1ONXVzTWJMLW1kY1BkMjMxRDVNdnZyWURZLUhuQnlBUTVwQkJ6N0FPSXJlS2d3MWhkdjJDWW41VEppcVk?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPcTNUb0lJOXM5dllVOV9ud0xKME85Zmd6dFBlQnJ4dk4tRjlRTlljODdXYURpWG5DVzNJcVBwTjgxT0twMldUamQ1NDU1M2JBNTFMSV92UjhaRmE3aE9RUjRxYkpZampfaW1xaGlIb2trT2RrNV9nM2Z3aFVVYW8tRnNhNnpGS2hUUVlVUkdUdEdJVzB2MjhzZ1J4RVRPMUVTNUE?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQSk5Tam03M2hFMms3ZzUxR0F3S3FfajFUUjk5cUNBdjNjd21rb2pnY3FZY2xDLXVzLWFRYS1IMy1nbmVTZS1MRDFKNzk1R2RpZHhGUmcxNGh4aUF6SlM2Ylo0ZGlTS1hlWW1mS2lTRjBsZWY2dDk3NVZXMEpNbUZtYWJtN2YtNldyTVRkNHlfWGVNZzhuRkVncW1jT18xenNXbGc?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics to Present at Bank of America 2026 Healthcare Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNMS1HazVXLWV2alFmNmJFRjBSYUxQY2JSVjFXQXUzVEZfdGFYTW5kbTNNT2tyUXdkdVNOVTVnd0k3MUhLMTZrMlZsZG0tTXItWWNKcGhHVUp6S2tYbXZ3b3RYcm5NQzNJRkIwb0JaZ2lIVmh1ZFJsSjFkeVhhUFVTZkhnSUJiQUVlOFMzWHFjMGVCSWwzMi02cllyX0wxc1h1SUdSdENES0VaeF8zNVBjSTRYMVdHQ2E1ZFhSSEtCb20ydw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Mizuho Adjusts Haemonetics Corporation (HAE) Estimates in Sector-Wide Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNQVRfdXNmczlocEo3dG9yby1tVk1ubk9BNHJTa1VoNm4tMmlaNzFuc2Zqa1d5cWYwbEtTVWdReURHTkswdDdMLWlxMDVJcWc3cS01ZXI5WmJHeGlDbk54T05nWTRWQWd5QUxIUFBWdkI3eHFIbWFqZFlEMWJ4RHRNUDYyTVJ0bjRnU19taXNWbmlxaFJNRjNlVlVkSFRleDM4LTJsbmtPckxyWnYxa3I3Ng?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "Haemonetics Price Target Raised to $90.00/Share From $85.00 by Mizuho", "summary": "Mizuho has raised its price target for Haemonetics (NYSE: HAE) to $90.00 per share, an increase from the previous target of $85.00. This adjustment in the price target indicates an updated valuation of the company by the analyst firm.", "url": "https://www.moomoo.com/news/post/73026893/haemonetics-price-target-raised-to-90-00-share-from-85", "source_name": "Moomoo", "published_at": "2026-07-16T00:12:16", "published_display": "16 Jul 2026 00:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Is Maintained at Outperform by Mizuho", "summary": "Mizuho has maintained its Outperform rating on Haemonetics (NYSE: HAE) with a price target of $125.00. This continued positive outlook suggests the analyst firm believes in the company's strong performance potential. Investors will likely watch Haemonetics' future financial resul", "url": "https://www.moomoo.com/news/post/73026894/haemonetics-is-maintained-at-outperform-by-mizuho?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-15T19:12:16", "published_display": "15 Jul 2026 19:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE Maintained by Mizuho -- Price Target Raised to $90", "summary": "Mizuho has maintained an Outperform rating for Haemonetics (HAE), raising its price target from $85.00 to $90.00. GuruFocus identifies HAE as 10.5% undervalued with a strong GF Score\u2122 of 87/100, citing high profitability, growth potential, and attractive valuation. Insiders have ", "url": "https://www.gurufocus.com/news/8960850/hae-maintained-by-mizuho-price-target-raised-to-90", "source_name": "GuruFocus", "published_at": "2026-07-15T19:10:41", "published_display": "15 Jul 2026 19:10", "sentiment": "positive", "sentiment_pct": 79, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Haemonetics Corp (HAE) a Bargain After 3.2% Drop? GF Value Sa", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOdUpkcXd2QTVWYzIxeEloRTV2d2tEOURtUE5MQ3M3OHVEb2lzY2lFTUpiX3BoV1N3WmpRTlZoTWh6VXVFUkprSEkzMXAwNkttREV0Sm1oZGRBTmRZaWpxb3REeEI3UkExa0NIdDBncUZfV0tTUThmX3JHRHgwcEVXaEVNU25saGhWa3VycHBjRU0xT1c2c25KcGIxUkM3RW1XZGliM0FMTTBaLW5Bbl9Ibmw2NjhjZGFkMWR0MWJKazctdw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T00:25:28+00:00", "published_display": "15 Jul 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE5817431 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the Haemonetics Corporation 2.5% 01-JUN-2029 bond (HAE5817431 FINRA). It details the issuer's description, issue and maturity dates, outstanding amount, face value, and coupon rate. The bond profile also includes a company overview of Haemone", "url": "https://www.tradingview.com/symbols/FINRA-HAE5817431/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T14:39:32", "published_display": "13 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Joins Russell Indexes As Investors Ask If The Stock Is Still Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNNXpGVlMzNG4xUURKaDU0cjRHYlh6N2ZVaVozTXNQZ0U3d0V5VjNBR2J2YlNrUnR1M1lNT3hHalJ0d2k1T29PV3ZqazI3SHEwNkJGZzFUS0VXYl8zeWMxaFpBNUtyZkVsWU1MYlFXUzFjM3VHb2dQN3E4NHAyRDRIajNHcG1TUEhOb2R6c1ZXdnFyZXo4ZUk2Vy1OVzJUaEZXMEpCZmR4SUNJZjJaQjJTY2tjMy1DMy03U3NnSWZTZzctMTVucjBNatIBzgFBVV95cUxNVjhseVh1SGNmMkpOVlVIbEctY2czbWZBa1E5MS1iRG4yUWZRSkJwZW5uMmpVcGJOSnNoeDR6bFR0MkJpRHB5MTdYcExaOHY0SnpyMWhsQ2psNFZYWEluemxQTGZDZS1fMUVRTlBHOEFuQWVHLWJVc2x4Y2VZMTFQRkFOOG1jbE40YjdVUm1laU5Hd1B3T0hkV3FzLUMzcTNXWHM1VEYtaTJSY3ktV3pvVUpQUVhVNXRqeE9icE40TF8tSFNESDRYT3JfcE40UQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T00:02:09+00:00", "published_display": "11 Jul 2026 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Downgrades Haemonetics (HAE)", "summary": "Raymond James has downgraded Haemonetics (HAE) stock from an \"Outperform\" rating to a \"Market Perform\" rating. This change reflects the analyst's updated view on the company's financial prospects and stock performance. Investors and market watchers often follow such downgrades as", "url": "https://www.msn.com/en-us/money/markets/raymond-james-downgrades-haemonetics-hae/ar-AA1Kp3KC?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-10T15:10:43", "published_display": "10 Jul 2026 15:10", "sentiment": "negative", "sentiment_pct": 15, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026", "summary": "Haemonetics has announced that it will release its first quarter fiscal year 2027 financial results on Thursday, August 6, 2026. The company will also host a conference call and webcast on the same day at 8:00 a.m. EDT to discuss these results. Interested parties can access the w", "url": "https://www.moomoo.com/news/post/72668040/press-release-haemonetics-sets-date-for-publishing-first-quarter-fiscal", "source_name": "Moomoo", "published_at": "2026-07-09T17:39:32", "published_display": "09 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE stock holds steady as investors track Haemonetics' product mix", "summary": "Haemonetics (HAE) stock remains in focus due to its blood-management and hospital product offerings, which form the core of its business model. The company, listed on the NYSE, specializes in medical technology for blood collection, plasma processing, and hospital workflows, rely", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/hae-stock-holds-steady-as-investors-track-haemonetics-product-mix/69733227", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:39:18", "published_display": "09 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026", "summary": "Haemonetics Corporation announced it will publish its first quarter fiscal year 2027 financial results on Thursday, August 6, 2026, at 6:00 am ET. The company will also host a conference call for investors and analysts at 8:00 am ET on the same day to discuss the results and answ", "url": "https://www.marketscreener.com/news/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2027-results-august-6-2026-ce7f5ed9dd8cf523", "source_name": "www.marketscreener.com", "published_at": "2026-07-08T20:10:37", "published_display": "08 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics sets Aug. 6 call for Q1 2027 results", "summary": "Haemonetics (NYSE: HAE) has announced that it will publish its first-quarter fiscal year 2027 financial results on Thursday, August 6, 2026, at 6:00 a.m. ET. The company will also host a conference call for investors and analysts at 8:00 a.m. ET on the same day to discuss the res", "url": "https://www.stocktitan.net/news/HAE/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2027-yrgjsj97ghh7.html", "source_name": "Stock Titan", "published_at": "2026-07-08T20:10:36", "published_display": "08 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp updates investors on blood management business. Operational focus supports long-ter HAEMONETICS CORP updates investors on blood management business. Operational focus supports long-term growth outlook", "summary": "Haemonetics Corp, a medical technology company specializing in blood management systems, continues to update investors on its operational focus. The company invests in core platforms and software tools to support hospitals and blood centers globally, aiming to improve patient car", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-updates-investors-on-blood-management-business/69705376", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T12:11:16", "published_display": "06 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Haemonetics Corporation \u2013 SWB:HAZ", "summary": "This article provides financial information for Haemonetics Corporation (SWB:HAZ), specifically focusing on its enterprise value to EBIT forward. It indicates that the market was closed with no trades recorded and presents a navigation link to financial data on TradingView.", "url": "https://www.tradingview.com/symbols/SWB-HAZ/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:11:16", "published_display": "06 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?", "summary": "Haemonetics Corporation (HAE) is poised for growth driven by its Plasma franchise and the NexSys PCS system. Despite strong performance in its Plasma business and the potential of new technology, concerns remain regarding its debt-burdened balance sheet and competitive market. Th", "url": "https://www.tradingview.com/news/zacks:ae2093cd5094b:0-is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-07-03T17:10:10", "published_display": "03 Jul 2026 17:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp updates plasma strategy, shares tracked against U.S. medtech peers", "summary": "Haemonetics Corp is adjusting its plasma collection strategy and focusing on growth in its key business lines, particularly automated plasmapheresis platforms and blood management systems for hospitals. The company provides equipment and software for plasma centers rather than ow", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-updates-plasma-strategy-shares-tracked-against-u-s/69654785", "source_name": "AD HOC NEWS", "published_at": "2026-06-29T18:39:28", "published_display": "29 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2500 Value Benchmark", "summary": "Haemonetics Corporation (NYSE: HAE), a medical technology company specializing in blood and plasma technologies, has been added to the Russell 2500 Value Benchmark. This inclusion is part of several recent additions to various Russell indices, reflecting increased recognition and", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2500-value-benchmark-ce7f5fdfdf8cfe23", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:40:21", "published_display": "29 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2000 Value Benchmark", "summary": "Haemonetics Corporation (NYSE: HAE), a medical technology company, has been added to the Russell 2000 Value Benchmark. This update reflects the company's position within the small-cap value segment of the market. The article also provides recent news and financial data for Haemon", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2000-value-benchmark-ce7f5fded18ef321", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:39:28", "published_display": "29 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation(NYSE: HAE) added to Russell 2000 Value-Defensive Index", "summary": "Haemonetics Corporation (NYSE: HAE) has been added to the Russell 2000 Value-Defensive Index. This medical technology company specializes in solutions for critical medical needs, including hospital technologies, plasma collection, and blood center products. The addition to the in", "url": "https://www.marketscreener.com/news/haemonetics-corporation-nyse-hae-added-to-russell-2000-value-defensive-index-ce7f5fdedb8afe24", "source_name": "marketscreener.com", "published_at": "2026-06-29T02:11:32", "published_display": "29 Jun 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics\u2019 Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE)", "summary": "Haemonetics Corporation (HAE) has been included in several Russell value and defensive indexes, which is expected to increase passive ownership and liquidity, reinforcing its position as a value-tilted medtech stock. While this inclusion will impact trading dynamics, the core inv", "url": "https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/haemonetics-broad-russell-value-index-inclusion-might-change", "source_name": "Simply Wall Street", "published_at": "2026-06-29T01:11:32", "published_display": "29 Jun 2026 01:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article provides financial information for Haemonetics Corporation (NYSE: HAE), specifically detailing its enterprise value to revenue forward metric. The content, sourced from TradingView, focuses on the company's financials within the Health Technology sector.", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T15:40:33", "published_display": "27 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article from TradingView displays the \"Price to sales forward\" financial metric for Haemonetics Corporation (NYSE:HAE). The page appears to be a financial data presentation without explanatory text, showing only the period, value, and change for this specific metric. It is p", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:40:21", "published_display": "27 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page provides financial data for Haemonetics Corporation (HAZ) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to revenue forward. It is a data-centric page without a narrative article.", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:40:21", "published_display": "27 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page from TradingView provides financial data for Haemonetics Corporation (FWB:HAZ), specifically its price to sales forward. It shows that the market is currently closed with no trades recorded for the stock. The content focuses purely on this financial metric without furth", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:09:45", "published_display": "27 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This page provides financial information for Haemonetics Corporation (NYSE: HAE), specifically detailing its forward Price to Earnings (P/E) ratio. The content is primarily a financial data point from TradingView, indicating no current trades for the company and listing various f", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T22:09:45", "published_display": "26 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Haemonetics Corporation \u2013 FWB:HAZ", "summary": "This page from TradingView provides financial information for Haemonetics Corporation (FWB:HAZ), specifically focusing on its Price to Earnings (forward) metric. It lists the company on the Frankfurt Stock Exchange within the Health Technology and Medical Specialties sectors. The", "url": "https://www.tradingview.com/symbols/FWB-HAZ/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:40:27", "published_display": "26 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Haemonetics Corporation \u2013 NYSE:HAE", "summary": "This article presents financial information for Haemonetics Corporation (NYSE: HAE), specifically focusing on its Enterprise Value to EBITDA (EV/EBITDA) forward metric. It highlights that this data point is accessible through the TradingView platform, which provides various finan", "url": "https://www.tradingview.com/symbols/NYSE-HAE/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:27", "published_display": "26 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corporation Actuals & Estimates (NYSE:HAE)", "summary": "This article provides financial actuals and estimates for Haemonetics Corporation (NYSE: HAE), including details on its stock performance, analyst forecasts, earnings, revenue, and market capitalization. It highlights the company's recent stock price movements, upcoming earnings ", "url": "https://www.tradingview.com/symbols/NYSE-HAE/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:29", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Haemonetics Corporation \u2013 SWB:HAZ", "summary": "This article provides financial data for Haemonetics Corporation (SWB:HAZ) on the Stuttgart Stock Exchange, specifically focusing on its Enterprise Value to EBITDA forward. The content appears to be a stub or a section within a larger financial platform, offering no specific valu", "url": "https://www.tradingview.com/symbols/SWB-HAZ/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:40:29", "published_display": "26 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp (HAE) Stock Up 6.5% and Still Undervalued -- GF Score: 84/100", "summary": "Haemonetics Corp (HAE) saw its stock rise by 6.5% to $77.62 on June 25, 2026, and is considered 8.5% undervalued compared to its GF Value\u2122 of $84.82. The company holds a strong GF Score\u2122 of 84/100, driven by high profitability and growth ranks, despite a neutral stance from insid", "url": "https://www.gurufocus.com/news/8932858/haemonetics-corp-hae-stock-up-65-and-still-undervalued-gf-score-84100", "source_name": "GuruFocus", "published_at": "2026-06-26T00:40:29", "published_display": "26 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAE Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Haemonetics Corporation (HAE) stock, including analyst price targets, current stock performance, and financial data. It covers historical prices, volatility, market capitalization, upcoming earnings reports, and revenue details, while also add", "url": "https://www.tradingview.com/symbols/NYSE-HAE/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T23:40:34", "published_display": "25 Jun 2026 23:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Jumps 5.9% Amid Sector-Wide Rally", "summary": "Haemonetics Corporation (HAE) saw its stock surge by 5.9% on Thursday, closing at $77.16 due to a broad sector-wide rally, not company-specific news. The strong performance, which included sector peers like QDEL and NEOG also making gains, suggests a general investor rotation int", "url": "https://news.alphastreet.com/haemonetics-jumps-5-9-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-06-25T19:39:48", "published_display": "25 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Corp (HAE) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Haemonetics Corp (HAE), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of June 18, 2026, HAE has a price momentum score of 9.04, trading between a resistance of ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hae/technical", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:45", "published_display": "17 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Haemonetics (HAE) Valuation After Its New Apheresis And MedSurg Segment Realignment", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/look-haemonetics-hae-valuation-apheresis-161042644.html", "source_name": "Simply Wall St.", "published_at": "2026-06-09T16:10:42+00:00", "published_display": "09 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HAEMONETICS CORP ($HAE) President and CEO 2026 Pay Revealed", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObUcxZ1dEN2czb05ac0FtaDlPTXo3RVNqUGgxTEZQYmMwcWZKSC1yUHBlRmQwOGR1QzdKNEp6MFlqS3VGcDNUeXRkU0RWRWN2MkdjVkM3SVZKUFJsTWQtN196NDJ4VzN4cnBkbW5ObGp5c1Bva0xGWTkyRFFoYTluTjJ5NG41dENES1R5eGZORzhRS045czhvcUZTOUUzVTA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Haemonetics (HAE) Stock Price Reflecting Its Recent 29% Monthly Surge Accurately", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Narrows Reporting Structure", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/haemonetics-narrows-reporting-structure-110406793.html", "source_name": "MT Newswires", "published_at": "2026-06-05T11:04:06+00:00", "published_display": "05 Jun 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics Updates Financial Reporting Segments", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/haemonetics-updates-financial-reporting-segments-103000347.html", "source_name": "PR Newswire", "published_at": "2026-06-05T10:30:00+00:00", "published_display": "05 Jun 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (NYSE: HAE) consolidates business into new Apheresis and MedSurg segments", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSWN6Q09vUkV6N2tYb2pURW16QXYzd2drQUk5OXRtWGctYzQzZXA0SWRTWllKX3JIQWpmRmFuckQ1aE9SSll1VGNUUWs5dVI1OUdKWlBpSnBPWFl3N204ckJJZzRBZzNxRGFjZ3NnUjFEQWdrbWQwREJIbGg0SEFTOUVZem9BRnNVdnVrWWNUdzFoU2c4NkQzYXkwSXM2NGltRVVzR0Z1TQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics' (NYSE:HAE) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWld5OTQtb2RiRDNtd2hRc1dhMGxRel9LS2JJWHY2OVNYNVAzNWRvWmxpQkZnd213LWdwZDRqczVhUFhNWV9OZTdSTXpIYnBJd2RzTkhlMzA0MktZdVVlaW85bXc3MW0tZF9KeE9MZ2lfTVBYY2s5UWpmem11REZuT3lHcmJQUjgzTlFDeFluZFRCVHh1NjZnZDkySkF3Q0VOLXhUaEpwd2R1UlJraFhxS25ER2taQmx2QS1KZGhQaEM3aVhWdE8yN9IBzgFBVV95cUxNemsxSzQ3REtiU0JYVHJlZFVMNnNCcGxIaWhGN1JWSnJfTGxyY2dyOExjNE1GemtEWjZLdm1SWUJCaHY4bHhXY1dXeWd6N2hZSzN4a1ZZdUVtYlItSmpCU09fcGtMWDQxV052UFJ0UnM0RWJBVFRDQnplUWxfem84NzFjQVV4ZS1kcjBYUlNxeXVLeGZxTEI2azNIc0dYcWdXcXBrNDd0YndlTnRBM1Z6aGtXdFRPZGtXZFhUSjFKb0JfWUFMeF82MmwyVFJBdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQRmNnMW43N2hBMDlEVV9IR09FdHFrb2pKTDJVX01qWUlVRlY5Yl9sNmZ1UTlBaGtaandPRUtiWTJOQUludWgxT09DbUZURnBHZmhjVTNqT05YYmVuY3pXY0t5NVFmU0dkYWkwNEIzalJzMXNRSmU0NWxiczR0a2JQUElPTGhBV1czeXoyUjJaaGFDd1U?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOWHZvUkljRWNUaEtTQTRmcEY1NkNnclNqaWlRRDB6WHhkRXV4OUxKR241NGh5Uk1xbEtHX3RObXhuYlQ5M2poVnc2MVJtTGNQcDRJOHhfbVJCWlN4bl9iRUhrMFpseHdSaHRJWWxZb1F0QjVIUndRZzlHUGJrRVZYbVVkdjJlbExOQVNzOXc3cFhjZUxHcGc?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics upgraded at BofA on conservative outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQTS05VzRjV0Jsa2ZRRVM4R2hhd19rbjRjSlJaLUlDaWp3cWNraERBTHJZMWhiRlF2TXA4OEZJaFM3LUNsREVubzYyR3pwVHNhQlZWeGlrYlBlVHY0Qy1sV3RERVJaNm5vVEU3emdVcWRqZHVHUFlZLWtiYzNDQkNoU2xxdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Haemonetics (HAE) Have Enduring Growth Potential?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNclJNOEJZNDgtZ0J0OVFxQkRxZmQycWUwVW1ObkxqZ3dkOXdQbW5IbWtRSmtoYVRBMVRqclh0NS1uUElPWkUxbkJGWllqZVFxYkhxUHZnYmI5eWZURTFBN09CRkFFSUl2ZUVBMkFJN0RzeTRZSWxNTzBQY1Y5WlVjVVlMR1BZMlNXVEtxc0RTX0phME8xLUFvSS02WkNoSFNiNm5F?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNaTE2aVBzMS16SVQzN0VoUGh3blViYmJYVmxRazVscjFzcjk0VkVXMEZUYU0zSERNTzE2SDFKX0RlV3ZQeVI0RUgzSFlFQXpOOW9uempQQXRiM2E1MElDSEtVd2JDakFFcDZpSEFkZDhBOHFCbUhQcFhlS19tY3FZN0ZJcUh5eEwzM1dVTUQ4TmUwMmFuczU3Q2REVUtUYlBPeUpQTg?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) One Off Loss And Margin Hit Challenge Bullish Earnings Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQcTBTVmNBNkptbHRuRm1mQ0FYT25HMlJxdmtjSXpWTUdTanUzSkJzczQ5bld2YVh2SHQyWFJoSFAxdUczME9RcVYyZk4xUWI5a0ZHSDRTQ0VGX3JTY3E3NExJVlhfVFVFeE5XZE1ONXVzTWJMLW1kY1BkMjMxRDVNdnZyWURZLUhuQnlBUTVwQkJ6N0FPSXJlS2d3MWhkdjJDWW41VEppcVk?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPcTNUb0lJOXM5dllVOV9ud0xKME85Zmd6dFBlQnJ4dk4tRjlRTlljODdXYURpWG5DVzNJcVBwTjgxT0twMldUamQ1NDU1M2JBNTFMSV92UjhaRmE3aE9RUjRxYkpZampfaW1xaGlIb2trT2RrNV9nM2Z3aFVVYW8tRnNhNnpGS2hUUVlVUkdUdEdJVzB2MjhzZ1J4RVRPMUVTNUE?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQSk5Tam03M2hFMms3ZzUxR0F3S3FfajFUUjk5cUNBdjNjd21rb2pnY3FZY2xDLXVzLWFRYS1IMy1nbmVTZS1MRDFKNzk1R2RpZHhGUmcxNGh4aUF6SlM2Ylo0ZGlTS1hlWW1mS2lTRjBsZWY2dDk3NVZXMEpNbUZtYWJtN2YtNldyTVRkNHlfWGVNZzhuRkVncW1jT18xenNXbGc?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Haemonetics to Present at Bank of America 2026 Healthcare Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNMS1HazVXLWV2alFmNmJFRjBSYUxQY2JSVjFXQXUzVEZfdGFYTW5kbTNNT2tyUXdkdVNOVTVnd0k3MUhLMTZrMlZsZG0tTXItWWNKcGhHVUp6S2tYbXZ3b3RYcm5NQzNJRkIwb0JaZ2lIVmh1ZFJsSjFkeVhhUFVTZkhnSUJiQUVlOFMzWHFjMGVCSWwzMi02cllyX0wxc1h1SUdSdENES0VaeF8zNVBjSTRYMVdHQ2E1ZFhSSEtCb20ydw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Haemonetics Corporation (HAE) Estimates in Sector-Wide Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNQVRfdXNmczlocEo3dG9yby1tVk1ubk9BNHJTa1VoNm4tMmlaNzFuc2Zqa1d5cWYwbEtTVWdReURHTkswdDdMLWlxMDVJcWc3cS01ZXI5WmJHeGlDbk54T05nWTRWQWd5QUxIUFBWdkI3eHFIbWFqZFlEMWJ4RHRNUDYyTVJ0bjRnU19taXNWbmlxaFJNRjNlVlVkSFRleDM4LTJsbmtPckxyWnYxa3I3Ng?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 107, "total_relevant": 68, "sentiment_summary": {"positive": 15, "negative": 2, "neutral": 51, "score": 55, "total": 68, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 18.7, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 12.24, "count": 25}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 76.19, "latest_week": "2026-07-10", "one_week_move": 1.5, "four_week_move": -2.6, "twelve_week_move": 23.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.917546, "market_dynamics_buy_signal": false, "relative_strength": 6.017022, "fair_value_gap": 2.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.2466, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.5% over one week, -2.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 15}, {"label": "TradingView", "count": 13}, {"label": "simplywall.st", "count": 4}, {"label": "Moomoo", "count": 3}, {"label": "GuruFocus", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "www.marketscreener.com", "count": 2}, {"label": "Stock Titan", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 57}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 25}, {"label": "Analyst action", "count": 4}, {"label": "Guidance", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "57", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.5% over one week, -2.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Haemonetics Price Target Raised to $90.00/Share From $85.00 by Mizuho"}], "updated_at": "2026-07-17T06:29:02.730648+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}